Press Releases

DIASORIN LAUNCHES THE SIMPLEXA™ C. AURIS DIRECT ASSAY ON THE LIAISON® MDXv INSTRUMENT IN ALL COUNTRIES ACCEPTING THE CE MARK

Diasorin announced the availability of its Simplexa C. Auris Direct kit in all countries accepting the CE mark. The targeted molecular diagnostic test is performed on the LIAISON MDX instrument, yielding patient results in less than two hours.

Clearwater Joins CancerX to Help Drive Strong Cybersecurity and Data Privacy Practices in the Fight Against Cancer

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

START's site network solidifies its global leadership in urological cancer trials.

Coronado Research Announce the Appointment of Nick Littlebury as EVP, Regulatory Affairs

Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle.

Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting

As Baylor Genetics celebrates a decade of leadership at the forefront of genetic testing, it is set to exhibit its latest scientific studies in genetic testing at the 2025 ACMG Annual Clinical Genetics Meeting, taking place March 18-22, 2025, in Los Angeles, CA. The Company will be located at Booth #217 at the Los Angeles Convention Center.

Clearwater Publishes First-of-its-Kind Report Examining Cybersecurity Performance of Private Equity-Backed Portfolio Companies in Healthcare

ClearNote Health’s Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev’s National PPO Networks

ClearNote Health announced an agreement with Claritev, Inc., (previously MultiPlan, Inc.) that will make ClearNote Health’s Avantect Pancreatic Cancer Test available to health plan members accessing Claritev’s national PHCS and MultiPlan Networks.

Augurex Announces UK Conformity Assessed (UKCA) Authorization for JOINTstat®, Expanding Access to Cutting-Edge Rheumatoid Arthritis Testing in Great Britain

Augurex has received UK Conformity Assessed marking for JOINTstat®, authorizing its use in Great Britain for rheumatoid arthritis diagnosis and management. JOINTstat® is a well-established rheumatoid arthritis blood test in North America, approved by Health Canada and available in the U.S. as a laboratory-developed test.

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

IQVIA Laboratories is introducing its Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites, aiming to significantly reduce administrative burden on sites and improve the quality and execution of trials.

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Thermo Fisher Scientific’s New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics

Today, Thermo Fisher Scientific launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System to offer scientists new capabilities to understand the organization of cells within tissues.

Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, marks its 10-year anniversary this month, a milestone that demonstrates the company’s long-term commitment to unlock the power of precision diagnostics, transform healthcare, and end the diagnostic odyssey for patients with the most complex genetic disorders.

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares New RNA Sequencing Insights for Rare Disease at Precision Medicine World Conference 2025

Christine Eng, M.D., chief medical officer and chief quality officer at Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will present on new RNA sequencing insights for rare disease as part of the Clinical Dx (Diagnostic) Showcase track at the Precision Medicine World Conference (PMWC) 2025.